Jennifer May, MD
Internal Medicine · Rapid City, SDNPI 1891765475
Payments from drug & device makers
Across 308 payments — averaging $168.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$48K
- AbbVie$597
- AstraZeneca$526
- Novartis$468
- UCB, Inc.$394
- Johnson & Johnson$300
- plus $2K from 14 others
What the payments were for
- Speaking & faculty fees$41,40080%
- Travel & lodging$4,2998%
- Food & beverage$6,07012%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 147 | $47,926 |
| AbbVie | 23 | $597 |
| AstraZeneca | 12 | $526 |
| Novartis | 22 | $468 |
| UCB, Inc. | 25 | $394 |
| Johnson & Johnson(2 entities) | 16 | $300 |
| Genentech USA, Inc. | 11 | $255 |
| GSK | 11 | $241 |
| Regeneron Healthcare Solutions, Inc. | 5 | $229 |
| Lilly USA, LLC | 11 | $191 |
| Genentech, Inc. | 1 | $125 |
| Sobi, Inc | 1 | $117 |
| Mallinckrodt Enterprises LLC | 4 | $107 |
| Aurinia Pharma U.S., Inc. | 3 | $91 |
| Pfizer | 5 | $81 |
| Radius Health, Inc. | 5 | $63 |
| Sandoz | 1 | $36 |
| Fresenius Kabi USA, LLC | 2 | $33 |
| Bristol Myers Squibb | 2 | $31 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,816 in reported general payments places this provider in the 95th percentile of 178 internal medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 38 | $249,789 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $137,177 |
| Enbrel SureclickEtanercept | 16 | $109,849 |
| Xeljanz XrTofacitinib Citrate | 18 | $107,034 |
| Cosentyx Unoready PenSecukinumab | 13 | $103,125 |
| Orencia ClickjectAbatacept | 13 | $65,480 |
| MethotrexateMethotrexate Sodium | 265 | $8,340 |
| Hydroxychloroquine Sulfate | 155 | $6,657 |
| Leflunomide | 46 | $1,628 |
| Prednisone | 214 | $1,547 |
| Allopurinol | 115 | $1,353 |
| Gabapentin | 88 | $1,131 |
| Mycophenolate Mofetil | 11 | $1,012 |
| Celecoxib | 16 | $933 |
| Sulfasalazine DrSulfasalazine | 12 | $732 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rapid City
- Richard BeasleyRapid City$4.6M
- Jeffrey HendersonRapid City$2.1M
- Issam TurkRapid City$14K
- David EvansRapid City$3K
- Eric ChowRapid City$1K
- Matthew WerpyRapid City$873
- Kenneth HartRapid City$372
- David EatonRapid City$357
- Shailesh ThapaRapid City$238
- Marisa MedinaRapid City$228
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.